Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Easton Capital
3811
Easton Capital
Suggest edits
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Bloomberg
Goldman Sachs
JPMorgan
Kickstarter
Wired
Morgan Stanley
The New York Times
Overview
News
Investments
20
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
bluebird bio (BLUE) Stock Price: Why It Surged Over 70% Today
Pulse 2.0
bluebird bio (BLUE) Stock Price: Why It Increased 21.14%
Pulse 2.0
bluebird bio (BLUE) Stock: $10 Price Target And Neutral Rating
$45,000,000
Venture capital (Series D)
FinSMEs
TigerConnect Closes $45M Series D Funding
$100,000,000
Venture capital
FinSMEs
Within3 Raises Over $100M in Growth Funding
TechCrunch
Ohio-based collaboration service for biotech and pharma research, Within3, raises $100 million
MedCity News
bluebird bio's stock tanks after report of serious toxicity in sickle cell patient
GeekWire
Providence St. Joseph Health family health app Circle acquired by Wildflower Health
Health
socalTECH.com
TigerText Becomes TigerConnect
$8,000,000
Venture capital (Series C)
FinSMEs
Wildflower Health Receives $8M in Funding
Funding
Health
$250,000,000
Post-IPO equity
Twitter
Boston Business on Twitter
The Motley Fool
Better Buy: Agenus Inc. vs. bluebird bio
The Motley Fool
Why Global Blood Therapeutics Inc. Skyrocketed and bluebird bio Inc. Sank Today
The Motley Fool
Better Buy: bluebird bio vs. Inovio Pharmaceuticals
The Motley Fool
Better Buy: Juno Therapeutics vs. bluebird bio
The Motley Fool
bluebird bio Inc: Catnapping in Cambridge
The Motley Fool
Forget Bluebird Bio, Inc.: These 3 Stocks Are Better Buys
The Motley Fool
bluebird bio, Inc. Takes Flight Towards First Approval
The Motley Fool
Here's Why bluebird bio.'s Stock Tumbled in March
The Motley Fool
Why bluebird bio's Stock Jumped 12.9% on Wednesday
